Meex, S. J. R., van der Kallen, C. J. H., van Greevenbroek, M. M., Eurlings, P. M., El Hasnaoui, M. M., Evelo, C. T., Lindsey, P. J., Luiken, J. J. F. P., Glatz, J. F., & de Bruin, T. W. (2005). Up-regulation of CD36/FAT in preadipocytes in familial combined hyperlipidemia. Faseb Journal, 19(14), 2063-2065. https://doi.org/10.1096/fj.04-2403fje

Dirksen, A., Langereis, S., de Waal, BFM., van Genderen, MHP., Hackeng, TM., & Meijer, EW. (2005). A supramolecular approach to multivalent target-specific MRI contrast agents for angiogenesis. Chemical Communications, (22), 2811-2813. https://doi.org/10.1039/b502347e

van Baal, W. M., Malda, H., Synowsky, SA., van Dongen, JLJ., Hackeng, TM., Merkx, M., & Meijer, EW. (2005). Multivalent peptide and protein dendrimers using native chemical ligation. Angewandte Chemie-International Edition, 44(32), 5052-5057. https://doi.org/10.1002/anie.200500635

Dirksen, A., Langereis, S., de Waal, BFM., van Genderen, MHP., Meijer, EW., de Lussanet, QG., & Hackeng, TM. (2004). Design and synthesis of a bimodal target-specific contrast agent for angiogenesis. Organic Letters, 6(26), 4857-4860. https://doi.org/10.1021/ol048084u

Spronk, H. M., van der Voort, D., & Ten Cate, H. (2004). Blood coagulation and the risk of atherothrombosis: a complex relationship. Thrombosis Journal, 2(1), 12. https://doi.org/10.1186/1477-9560-2-12

Sere, KM., Rosing, J., & Hackeng, TM. (2004). Inhibition of thrombin generation by protein S at low procoagulant stimuli: implications for maintenance of the hemostatic balance. Blood, 104(12), 3624-3630. https://doi.org/10.1182/blood-2004-03-1146

Heeb, MJ., Koenen, RR., Fernandez, JA., & Hackeng, TM. (2004). Direct anticoagulant activity of protein S-C4b binding protein complex in Heerlen heterozygotes and normals. Journal of Thrombosis and Haemostasis, 2(10), 1766-1773. https://doi.org/10.1111/j.1538-7836.2004.00901.x

Koenen, RR., Gomes, L., Tans, G., Rosing, J., & Hackeng, TM. (2004). The Ser460Pro mutation in recombinant protein S Heerlen does not affect its APC-cofactor and APC-independent anticoagulant activities. Thrombosis and Haemostasis, 91(6), 1105-1114. https://doi.org/10.1160/TH04-02-0082

Soute, B. A. M., Jin, D.-Y., Spronk, H. M. H., Mutucumarana, V. P., Lin, P.-J., Hackeng, T. M., Stafford, D. W., & Vermeer, C. (2004). Characteristics of recombinant W501S mutated human gamma-glutamyl carboxylase. Journal of Thrombosis and Haemostasis, 2(4), 597-604. https://doi.org/10.1111/j.1538-7836.2004.00686.x

Keuren, J. F. W., Wielders, S. J. H., Driessen, A., Verhoeven, M., Hendriks, M., & Lindhout, T. (2004). Covalently-bound heparin makes collagen thromboresistant.Arteriosclerosis Thrombosis and Vascular Biology, 24(3), 613-617. https://doi.org/10.1161/01.ATV.0000116026.18945.66

Scheffer, P. G., Henry, R. M. A., Wever, E. J. M., van Rooij, G. J., Bos, G. M. J., Heine, R. J., Dekker, J. M., Diamant, M., Stehouwer, C. D. A., Nijpels, G., Blankenstein, M. A., & Teerlink, T. (2004). LDL oxidative modifications in well- or moderately controlled type 2 diabetes. Diabetes-metabolism Research and Reviews, 20(4), 298-304. https://doi.org/10.1002/dmrr.461

Beerenhout, C., Noris, M., Kooman, J. P., Porrati, F., Binda, E., Morigi, M., Bekers, O., van der Sande, F. M., Todeschini, M., Macconi, D., Leunissen, K. M. L., & Remuzzi, F. R. C. P. (2004). Nitric oxide synthetic capacity in relation to dialysate temperature. Blood Purification, 22(2), 203-209. https://doi.org/10.1159/000076854

Spijkerman, A. M., Henry, R. M. A., Dekker, J. M., Nijpels, G., Kostense, P. J., Kors, J. A., Ruwaard, D., Stehouwer, C. D. A., Bouter, L. M., & Heine, R. J. (2004). Prevalence of macrovascular disease amongst type 2 diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the Hoorn Screening Study. Journal of Internal Medicine, 256(5), 429-436. https://doi.org/10.1111/j.1365-2796.2004.01395.x

Snijder, M. B., Henry, R. M. A., Visser, M., Dekker, J. M., Seidell, J. C., Ferreira, I., Bouter, L. M., Yudkin, J. S., Westerhof, N., & Stehouwer, C. D. A. (2004). Regional body composition as a determinant of arterial stiffness in the elderly: The Hoorn Study. Journal of Hypertension, 22(12), 2339-2347. https://doi.org/10.1097/00004872-200412000-00016

van Boxtel, M. P. J., Menheere, P. P. C. A., Bekers, O., Hogervorst, E., & Jolles, J. (2004). Thyroid function, depressed mood, and cognitive performance in older individuals: the Maastricht Aging Study. Psychoneuroendocrinology, 29(7), 891-898. https://doi.org/10.1016/j.psyneuen.2003.08.002

Spronk, H. M. H., Soute, B. A. M., Schurgers, L. J., Thijssen, H. H. W., De Mey, J. G. R., & Vermeer, C. (2003). Tissue-specific utilization of menaquinone-4 results in the prevention of arterial calcification in warfarin-treated rats. Journal of Vascular Research, 40(6), 531-7. https://doi.org/10.1159/000075344

Spronk, H. M. H., Govers-Riemslag, J. W. P., & ten Cate, H. (2003). The blood coagulation system as a molecular machine. Bioessays, 25(12), 1220-8. https://doi.org/10.1002/bies.10360

Koenen, RR., Tans, G., van Oerle, R., Hamulyak, K., Rosing, J., & Hackeng, TM. (2003). The APC-independent anticoagulant activity of protein S in plasma is decreased by elevated prothrombin levels due to the prothrombin G20210A mutation. Blood, 102(5), 1686-1692. https://doi.org/10.1182/blood-2003-02-0620

Rothkrantz-Kos, S., Bekers, O., Gubbels, A., Drent, M., Schmitz, M. P., & van Dieijen-Visser, M. P. (2003). Evaluation of two new high-sensitivity methods for C-reactive protein. Annals of Clinical Biochemistry, 40(Pt 4), 398-405. https://doi.org/10.1258/000456303766477057

Briedé, J. J., Wielders, S. J. H., Heemskerk, J. W. M., Baruch, D., Hemker, H. C., & Lindhout, T. (2003). von Willebrand factor stimulates thrombin-induced exposure of procoagulant phospholipids on the surface of fibrin-adherent platelets. Thrombosis and Haemostasis, 1(3), 559-565. https://doi.org/10.1046/j.1538-7836.2003.00077.x

Rothkrantz-Kos, S., Schmitz, M. P. J., Bekers, O., Menheere, P. P. C. A., & van Dieijen-Visser, M. P. (2002). High-sensitivity C-reactive protein methods examined. Clinical Chemistry, 48(2), 359-362. https://doi.org/10.1093/CLINCHEM/48.2.359

Dhore, C. R., Cleutjens, J. P., Lutgens, E., Cleutjens, K. B., Geusens, P. P., Kitslaar, P. J., Tordoir, J. H., Spronk, H. M., Vermeer, C., & Daemen, M. J. (2001). Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arteriosclerosis Thrombosis and Vascular Biology, 21(12), 1998-2003. https://doi.org/10.1161/hq1201.100229

Spronk, H. M., Soute, B. A., Schurgers, L. J., Cleutjens, J. P., Thijssen, H. H., De Mey, J. G., & Vermeer, C. (2001). Matrix Gla protein accumulates at the border of regions of calcification and normal tissue in the media of the arterial vessel wall. Biochemical and Biophysical Research Communications, 289(2), 485-90. https://doi.org/10.1006/bbrc.2001.5996

Mousallem, M., Spronk, H. M., Sacy, R., Hakime, N., & Soute, B. A. (2001). Congenital combined deficiencies of all vitamin K-dependent coagulation factors. Thrombosis and Haemostasis, 86(5), 1334-1336. https://doi.org/10.1055/s-0037-1616072

Farzaneh-Far, A., Davies, J. D., Braam, L. A., Spronk, H. M., Proudfoot, D., Chan, S. W., O'Shaughnessy, K. M., Weissberg, P. L., Vermeer, C., & Shanahan, C. M. (2001). A polymorphism of the human matrix gamma-carboxyglutamic acid protein promoter alters binding of an activating protein-1 complex and is associated with altered transcription and serum levels. Journal of Biological Chemistry, 276(35), 32466-73. https://doi.org/10.1074/jbc.M104909200

Sere, KM., Janssen, MP., Willems, GM., Tans, G., Rosing, J., & Hackeng, TM. (2001). Purified protein S contains multimeric forms with increased APC-independent anticoagulant activity. Biochemistry, 40(30), 8852-8860. https://doi.org/10.1021/bi002500a

Hackeng, T. M., Rosing, J., Spronk, H. M., & Vermeer, C. (2001). Total chemical synthesis of human matrix Gla protein. Protein Science, 10(4), 864-70. https://doi.org/10.1110/ps.44701

Schurgers, L. J., Dissel, P. E., Spronk, H. M., Soute, B. A., Dhore, C. R., Cleutjens, J. P., & Vermeer, C. (2001). Role of vitamin K and vitamin K-dependent proteins in vascular calcification. Zeitschrift fur Kardiologie, 90 Suppl 3, 57-63. https://doi.org/10.1007/s003920170043

Hackeng, TM., Fernandez, JA., Dawson, PE., Kent, SBH., & Griffin, JH. (2000). Chemical synthesis and spontaneous folding of a multidomain protein: Anticoagulant microprotein S. Proceedings of the National Academy of Sciences of the United States of America, 97(26), 14074-14078. https://doi.org/10.1073/pnas.260239797

Spronk, H. M., Farah, R. A., Buchanan, G. R., Vermeer, C., & Soute, B. A. (2000). Novel mutation in the gamma-glutamyl carboxylase gene resulting in congenital combined deficiency of all vitamin K-dependent blood coagulation factors. Blood, 96(10), 3650-3652. https://doi.org/10.1182/blood.V96.10.3650

Hackeng, TM., Yegneswaran, S., Johnson, AE., & Griffin, JH. (2000). Conformational changes in activated protein C caused by binding of the first epidermal growth factor-like module of protein S. Biochemical Journal, 349, 757-764. https://doi.org/10.1042/bj3490757

Braam, L. A., Dissel, P., Gijsbers, B. L., Spronk, H. M., Hamulyák, K., Soute, B. A., Debie, W., & Vermeer, C. (2000). Assay for human matrix gla protein in serum: potential applications in the cardiovascular field. Arteriosclerosis Thrombosis and Vascular Biology, 20(5), 1257-61. https://doi.org/10.1161/01.atv.20.5.1257

Marx, PF., Hackeng, TM., Dawson, PE., Griffin, JH., Meijers, JCM., & Bouma, BN. (2000). Inactivation of active thrombin-activable fibrinolysis inhibitor takes place by a process that involves conformational instability rather than proteolytic cleavage. Journal of Biological Chemistry, 275(17), 12410-12415. https://doi.org/10.1074/jbc.275.17.12410

Fernandez, JA., Kojima, K., Petaja, J., Hackeng, TM., & Griffin, JH. (2000). Cardiolipin enhances protein C pathway anticoagulant activity. Blood Cells Molecules and Diseases, 26(2), 115-123. https://doi.org/10.1006/bcmd.2000.0285

Deguchi, H., Fernandez, JA., Hackeng, TM., Banka, CL., & Griffin, JH. (2000). Cardiolipin is a normal component of human plasma lipoproteins. Proceedings of the National Academy of Sciences of the United States of America, 97(4), 1743-1748. https://doi.org/10.1073/pnas.97.4.1743

Hackeng, TM., Griffin, JH., & Dawson, PE. (1999). Protein synthesis by native chemical ligation: Expanded scope by using straightforward methodology. Proceedings of the National Academy of Sciences of the United States of America, 96(18), 10068-10073. https://doi.org/10.1073/pnas.96.18.10068

Curvers, J., Christella, M., Thomassen, L. G. D., Nicolaes, G. A. F., van Oerle, R., Hamulyak, K., Hemker, H. C., Tans, G., & Rosing, J. (1999). Acquired APC resistance and oral contraceptives: Differences between two functional tests. British Journal of Haematology, 105(1), 88-94. https://doi.org/10.1111/j.1365-2141.1999.01302.x

Wang, LL., Zoppe, M., Hackeng, TM., Griffin, JH., Lee, K.-F., & Verma, IM. (1997). A factor IX-deficient mouse model for hemophilia B gene therapy. Proceedings of the National Academy of Sciences of the United States of America, 94(21), 11563-11566. https://doi.org/10.1073/pnas.94.21.11563

Wielders, S., Mukherjee, M., Michiels, J., Rijkers, D. T. S., Cambus, J.-P., Knebel, R. W. C., Kakkar, V., Hemker, H. C., & Beguin, S. (1997). The routine determination of the endogenous thrombin potential, first results in different forms of hyper- and hypocoagulability. Thrombosis and Haemostasis, 77(4), 629-636. https://doi.org/10.1055/s-0038-1656024

Rosing, J., Tans, G., Nicolaes, G. A. F., Thomassen, M. C. G. L. D., van Oerle, R., van der Ploeg, P. M. E. N., Heijnen, P., Hamulyak, K., & Hemker, H. C. (1997). Oral contraceptives and venous thrombosis: Different sensitives to activated protein C in women using second-and third-generation oral contraceptives. British Journal of Haematology, 97(1), 233-238. https://doi.org/10.1046/j.1365-2141.1997.192707.x

KOPPELMAN, SJ., HACKENG, TM., SIXMA, JJ., & BOUMA, BN. (1995). INHIBITION OF THE INTRINSIC-FACTOR-X ACTIVATING COMPLEX BY PROTEIN-S - EVIDENCE FOR A SPECIFIC BINDING OF PROTEIN-S TO FACTOR-VIII. Blood, 86(3), 1062-1071. https://doi.org/10.1182/blood.V86.3.1062.1062

VANTVEER, C., HACKENG, TM., BIESBROECK, D., SIXMA, JJ., & BOUMA, BN. (1995). INCREASED PROTHROMBIN ACTIVATION IN PROTEIN S-DEFICIENT PLASMA UNDER FLOW CONDITIONS ON ENDOTHELIAL-CELL MATRIX - AN INDEPENDENT ANTICOAGULANT FUNCTION OF PROTEIN-S IN PLASMA. Blood, 85(7), 1815-1821. https://doi.org/10.1182/blood.V85.7.1815.bloodjournal8571815

VANTVEER, C., HACKENG, TM., DELAHAYE, C., SIXMA, JJ., & BOUMA, BN. (1994). ACTIVATED FACTOR-X AND THROMBIN FORMATION TRIGGERED BY TISSUE FACTOR ON ENDOTHELIAL-CELL MATRIX IN A FLOW MODEL - EFFECT OF THE TISSUE FACTOR PATHWAY INHIBITOR. Blood, 84(4), 1132-1142. https://doi.org/10.1182/blood.V84.4.1132.1132

Hemker, H. C., Wielders, S., Kessels, H., & Beguin, S. (1993). Continuous registration of thrombin generation in plasma: Its use for the determination of the thrombin potential. Thrombosis and Haemostasis, 70(4), 617-624. https://doi.org/10.1055/s-0038-1649638

Beguin, S., Wielders, S., Lormeau, J. C., & Hemker, H. C. (1992). The Mode of Action of CY216 and CY222 in Plasma. Thrombosis and Haemostasis, 67(1), 33-41. https://doi.org/10.1055/s-0038-1648375

Hemker, H. C., Beguin, S., Bendetowicz, A. V., & Wielders, S. (1991). Determination of the levels of unfractionated and low-molecular-weight heparins in plasma: Their effect on thrombin-mediated feedback reactions in vivo. Haemostasis, 21(4), 258-272. https://doi.org/10.1159/000216235